The differential diagnosis of chorea

Practical Neurology

Volumn 7, Issue 6, 2007, Pages 360-373

  Wild, E J ^a   Tabrizi, S J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; COCAINE; CONJUGATED ESTROGEN; CORTICOSTEROID; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IMMUNOGLOBULIN; LEVODOPA; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; RISPERIDONE; SULPIRIDE; TETRABENAZINE; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGGRESSION; ANTIPHOSPHOLIPID SYNDROME; ANXIETY DISORDER; AUTOIMMUNE DISEASE; CEREBROVASCULAR ACCIDENT; CHOREA; CHOREA MINOR; CHOREA-ACANTHOCYTOSIS; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYNDROME; FRIEDREICH ATAXIA; FUNCTIONAL DISEASE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; HEMOSIDEROSIS; HUMAN; HUNTINGTON CHOREA; HUNTINGTON CHOREA LIKE SYNDROME TYPE 1; HUNTINGTON CHOREA LIKE SYNDROME TYPE 2; HUNTINGTON CHOREA LIKE SYNDROME TYPE 3; HYPERKINESIA; HYPERTRANSLUCENT LUNG; IRRITABILITY; LABORATORY TEST; LOW DRUG DOSE; MITOCHONDRIAL DNA DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PLASMAPHERESIS; POLYCYTHEMIA VERA; PREGNANCY; PREVALENCE; PRION DISEASE; PSYCHOSIS; REVIEW; SEDATION; SIDE EFFECT; SPINOCEREBELLAR DEGENERATION; SUICIDE; SUICIDE ATTEMPT; SYSTEMIC LUPUS ERYTHEMATOSUS; TARDIVE DYSKINESIA; THYROTOXICOSIS; WILSON DISEASE;

ANTI-DYSKINESIA AGENTS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BASAL GANGLIA DISEASES; BRAIN DISEASES, METABOLIC; CHOREA; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; NEUROLOGIC EXAMINATION;

EID: 36949023982     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/pn.2007.134585     Document Type: Review

References (40)

1. Krack P. Relicts of dancing mania: the dancing procession of Echternach. Neurology 1999;53:2169-72.
2. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
3. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59:16-22.
4. Kremer B, Almqvist E, Theilmann J, et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet 1995;57:343-50.
5. Brandt J, Bylsma FW, Gross R, et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527-31.
6. Langbehn DR, Brinkman RR, Falush D, et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-77.
7. Li JL, Hayden MR, Almqvist EW, et al. A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study. Am J Hum Genet 2003;73:682-7.
8. Kremer B. Clinical neurology of Huntington's disease. In: Harper PS, ed. Huntington's disease. Oxford: Oxford Medical Publications, 2002.
9. Lasker AG, Zee DS. Ocular motor abnormalities in Huntington's disease. Vision Res 1997;37:3639-45.
10. Craufurd D, Snowden J. Neuropsychological and neuropsychiatric aspects of Huntington's disease. In: Harper PS, ed. Huntington's disease. Oxford: Oxford Medical Publications, 2002.
11. Farrer LA. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 1986;24:305-11.
12. Bonelli RM, Hofmann P. A systematic review of the treatment studies in Huntington's disease since 1990. Expert Opin Pharmacother 2007; 8:141-53.
13. Stevanin G, Fujigasaki H, Lebre A-S, et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 2003;126:1599-603.
14. Margolis RL, Holmes SE, Rosenblatt A, et al. Huntington's disease-like 2 (HDL2) in North America and Japan. Ann Neurol 2004;56:670-4.
15. Schols L, Bauer P, Schmidt T, et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
16. Machado A, Chien HF, Deguti MM, et al. Neurological manifestations in Wilson's disease: report of 119 cases. Mov Disord 2006; 21:2192-6.
17. Caer M, Viala K, Levy R, et al. Adult-onset chorea and mitochondrial cytopathy. Mov Disord 2005;20:490-2.
18. Chinnery PF, Crompton DE, Birchall D, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460lnsA mutation. Brain 2007;130:110-19.
19. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006; 59:248-56.
20. Ueno S, Maruki Y, Nakamura M, et al. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Genet 2001;28:121-2.
21. Danek A, Walker RH. Neuroacanthocytosis. Curr Opin Neurol 2005; 18:386-92.
22. Breedveld GJ, Percy AK, MacDonald ME, et al. Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 2002; 59:579-84.
23. Schrag A, Quinn NP, Bhatia KP, et al. Benign hereditary chorea-entity or syndrome? Mov Disord 2000;15:280-8.
24. Hanna MG, Davis MB, Sweeney MG, et al. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord 1998;13:339-40.
25. Piccolo I, Defanti CA, Soliveri P, et al. Cause and course in a series of patients with sporadic chorea. J Neurol 2003; 250:429-35.
26. Cardoso F, Silva CEAP, Mota CCC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord 1997;12:701-3.
27. Ghika-Schmid F, Ghika J, Regli F, et al. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci 1997;146:109-16.
28. Church AJ, Cardoso F, Dale RC, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002;59:227-31.
29. Cardoso F, Maia D, César M, et al. Treatment of Sydenham chorea with corticosteroids. Mov Disord 2003;18:1374-7.
30. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354:1153-8.
31. Marschitz I, Rodl S, Gruber-Sedlmayr U, et al. Severe chorea with positive anti-basal ganglia antibodies after herpes encephalitis. J Neurol Neurosurg Psychiatry 2007;78:105-7.
32. Jain KK. Drug-induced movement disorders. Drug-induced neurological disorders. Seattle: Hogrefe & Huber, 1996.
33. Miranda M, Cardoso F, Giovannoni G, et al. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry 2004;75:327-8.
34. Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997;76:203-12.
35. Isaacs JD, Rakshi J, Baker R, et al. Chorea associated with thyroxine replacement therapy. Mov Disord 2005;20:1656-7.
36. Tse W, Cersosimo MG, Gracies JM, et al. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 2004;10:323-34.
37. Dike GL. Chorea gravidarum: a case report and review. Md Med J 1997;46:436-9.
38. Nazabal ER, Lopez JM, Perez PA, et al. Chorea disclosing deterioration of polycythaemia vera. Postgrod Med J 2000; 76:658-9.
39. Cao M, Olsen RJ, Zu Y. Polycythemia vera: new clinicopathologic perspectives. Arch Pathol Lab Med 2006;130:1126-32.
40. International Huntington Association and World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994;44:1533-6.